ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

PHASE4CompletedINTERVENTIONAL
Enrollment

329

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2011

Study Completion Date

November 30, 2011

Conditions
Human Immunodeficiency Virus (HIV)
Interventions
DRUG

Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz)

Truvada (tenofovir 300mg qd + 200mg qd) once daily Efavirenz 600mg qd once daily

DRUG

Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV)

Tuvada (tenofovir 300mg qd + 200mg qd) once daily ritoanvir/atazanavir 100mg/300mg qd once daily (taken with food)

DRUG

Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC)

Tuvada (tenofovir 300mg qd + 200mg qd) once daily zidovudine 250mg/300mg qd (taken in two equal doses approximately 12 hours apart) Abacavir 600mg qd

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The University of New South Wales

OTHER

lead

Kirby Institute

OTHER_GOV

NCT00335322 - ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens | Biotech Hunter | Biotech Hunter